SG52704A1 - Specamycin derivatives and the use thereof - Google Patents

Specamycin derivatives and the use thereof

Info

Publication number
SG52704A1
SG52704A1 SG1996008096A SG1996008096A SG52704A1 SG 52704 A1 SG52704 A1 SG 52704A1 SG 1996008096 A SG1996008096 A SG 1996008096A SG 1996008096 A SG1996008096 A SG 1996008096A SG 52704 A1 SG52704 A1 SG 52704A1
Authority
SG
Singapore
Prior art keywords
chem
denotes
integer
carbon atoms
given number
Prior art date
Application number
SG1996008096A
Other languages
English (en)
Inventor
Atsuo Odagawa
Hiroyuki Kawai
Masaru Kamishohara
Noboru Otake
Tomiko Kawasaki
Teruyuki Sakai
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of SG52704A1 publication Critical patent/SG52704A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996008096A 1991-07-12 1992-07-10 Specamycin derivatives and the use thereof SG52704A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19890391 1991-07-12
JP32684591 1991-11-15
JP4110665A JP2783722B2 (ja) 1991-07-12 1992-04-03 スピカマイシン誘導体およびそれを含む抗腫瘍剤

Publications (1)

Publication Number Publication Date
SG52704A1 true SG52704A1 (en) 1998-09-28

Family

ID=27311786

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008096A SG52704A1 (en) 1991-07-12 1992-07-10 Specamycin derivatives and the use thereof

Country Status (16)

Country Link
US (2) US5461036A (de)
EP (1) EP0525479B1 (de)
JP (1) JP2783722B2 (de)
KR (1) KR100253050B1 (de)
AT (1) ATE159948T1 (de)
AU (1) AU657551B2 (de)
CA (1) CA2073567C (de)
DE (1) DE69222992T2 (de)
DK (1) DK0525479T3 (de)
ES (1) ES2111019T3 (de)
FI (1) FI105815B (de)
GR (1) GR3025293T3 (de)
HK (1) HK1001729A1 (de)
HU (1) HU221808B1 (de)
NO (1) NO178500C (de)
SG (1) SG52704A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7017208B2 (en) * 1995-08-04 2006-03-28 Hill-Rom Services, Inc. Hospital bed
US5905069A (en) * 1998-01-26 1999-05-18 The General Hospital Corporation Methods of decreasing or preventing pain using spicamycin or derivatives thereof
KR100787254B1 (ko) * 1999-01-22 2007-12-20 기린 홀딩스 가부시키가이샤 퀴놀린유도체 및 퀴나졸린유도체
EP2305264A1 (de) 2000-09-20 2011-04-06 The General Hospital Corporation Spicamicyn-derivate zur Verwendung in der Verminderung oder Verhinderung von Schmerzen
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
MXPA05005338A (es) * 2002-11-18 2005-12-14 Vicuron Pharm Inc Metodos para administrar dalbavancin para el tratamiento de infecciones bacterianas.
EP2154127A3 (de) * 2003-09-11 2010-10-13 Invista Technologies S.à.r.l. Umwandlung von hydrocyanierten ungesättigten Carboxylsäurederivaten zu Aminen
JP4608651B2 (ja) * 2004-06-24 2011-01-12 財団法人ヒューマンサイエンス振興財団 抗ガン作用を有する化合物、その製造方法及び抗ガン剤
US8119829B2 (en) * 2004-09-08 2012-02-21 Invista North America S.A.R.L. Process of hydrocyanation of unsaturated carboxylic acid derivatives
WO2010042212A2 (en) 2008-10-10 2010-04-15 Dara Biosciences, Inc. Methods for treating or preventing pain using spicamycin derivatives
EP2597082A1 (de) 2011-11-24 2013-05-29 Symrise AG Verbindungen zur Maskierung eines unangenehmen Geschmacks
AU2013299560A1 (en) 2012-08-09 2015-02-26 Dara Biosciences, Inc. Compositions comprising spicamycin derivatives and methods of use thereof
WO2015061481A1 (en) 2013-10-23 2015-04-30 Dara Biosciences, Inc. Methods of treating liquid tumors using compositions comprising spicamycin derivatives
CN110386874B (zh) * 2018-04-16 2022-10-04 湖北金鹤化工有限公司 一种12-酮基硬脂酸酯及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155647A (en) 1963-07-24 1964-11-03 Olin Mathieson Septaciding and derivatives thereof
US3264195A (en) * 1963-07-24 1966-08-02 Squibb & Sons Inc Process for the preparation of septacidin and derivatives
US4086416A (en) * 1977-05-17 1978-04-25 Stanford Research Institute Septacidin analogs
JPS59161389A (ja) * 1983-03-07 1984-09-12 Eisai Co Ltd ７−カルボキシメトキシフエニルアセトアミドセフエム誘導体，その製造法およびそれからなる抗菌剤
JPS59161396A (ja) * 1983-03-04 1984-09-12 Kirin Brewery Co Ltd 新規抗生物質スピカマイシン
US4975434A (en) * 1986-05-27 1990-12-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antiviral and anticancer cyclopentenyl cytosine
WO1990015811A1 (en) 1989-06-16 1990-12-27 Kirin Beer Kabushiki Kaisha Spicamycin x and its use

Also Published As

Publication number Publication date
ATE159948T1 (de) 1997-11-15
CA2073567C (en) 1998-05-05
ES2111019T3 (es) 1998-03-01
GR3025293T3 (en) 1998-02-27
DE69222992D1 (de) 1997-12-11
NO178500C (no) 1996-04-10
AU657551B2 (en) 1995-03-16
HU9202285D0 (en) 1992-10-28
FI923170A0 (fi) 1992-07-09
NO922674D0 (no) 1992-07-08
CA2073567A1 (en) 1993-01-13
EP0525479A1 (de) 1993-02-03
JPH05186494A (ja) 1993-07-27
HUT61773A (en) 1993-03-01
NO922674L (no) 1993-01-13
EP0525479B1 (de) 1997-11-05
KR100253050B1 (ko) 2000-04-15
HU221808B1 (hu) 2003-01-28
AU1960092A (en) 1993-01-14
FI105815B (fi) 2000-10-13
US5461036A (en) 1995-10-24
US5631238A (en) 1997-05-20
KR930002370A (ko) 1993-02-23
HK1001729A1 (en) 1998-07-03
JP2783722B2 (ja) 1998-08-06
NO178500B (no) 1996-01-02
DK0525479T3 (da) 1998-04-20
FI923170A (fi) 1993-01-13
DE69222992T2 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
EP0694558A4 (de) Sphingoglycolipid und verwendung davon
HK1001729A1 (en) Spicamycin derivatives and the use thereof
TW261533B (de)
EP0416117A4 (en) Liquid crystal composition
YU49175B (sh) Postupak za dobijanje derivata bakatina iii i 10-dezacetil-bakatina iii
DE3875346D1 (de) Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten.
TW337985B (en) "N-(B-branched alkyl)-1, 2-benzisothiolin, 3ones, their preparation and their use as industrial biocides"
GR3020635T3 (en) Polysiloxanic stabilizers containing sterically hindered phenol groups and oxamidic groups
GB9320299D0 (en) Isoxazole derivatives
AU641686B2 (en) Benzanilides
MY106839A (en) Carboxylate compounds, liquid crystal compositions containing said compounds and liquid crystal elements.
DK606286A (da) Anthracyclin-derivater og laegemidler indeholdende disse forbindelser
EP0418922A3 (en) Mesomorphic compound, liquid crystal composition containing same and liquid crystal device using same
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
DE3275083D1 (en) Cycloaliphatic alcohols
AU1810692A (en) Novel 1,5-diyne-3-cycloalkenes, process for their preparation and the pharmaceutical compositions containing said compounds
TH13348EX (th) อนุพันธ์ 1-เมธิลคาร์แบพีเนม การเตรียมสารเหล่านั้นและการใช้สารเหล่านั้นเป็นสารปฏิชีวนะ